Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
12/2004
12/02/2004US20040241854 Mammalian cells comprising rna sequences directed towards gene which codes transcript for swedish double amyloid precursor protein mutation or a transcript for tau gene product for use in posttranscriptional gene silencing and treatment of alzheimer's disease; gene therapy
12/02/2004US20040241851 Conditional knockout method for gene trapping and gene targeting using an inducible gene silencer
12/02/2004US20040241799 Methods of directing C-O bond formation utilizing a type II polyketide synthase system
12/02/2004US20040241796 Kinase for use as tool in identification of modulators for treatment and prevention of diabetic, cell prolliferative, cardiovascular and respiratory system disorders
12/02/2004US20040241740 Lafora's disease gene
12/02/2004US20040241738 Detection of binding reactions using labels detected by mediated catalytic electrochemistry
12/02/2004US20040241731 Methods of producing nucleic acid ligands
12/02/2004US20040241725 Lung cancer detection
12/02/2004US20040241720 Sodium activated potassium ion channel for therapeutic drug screening
12/02/2004US20040241717 Oligomeric compounds for the modulation of thioredoxin expression
12/02/2004US20040241714 Methods of assessment of drug metabolizing enzymes
12/02/2004US20040241713 Composition for immobilization of biological macromolecules in hydrogels, a method for preparing a composition, a biochip, and a method for performing the PCR over biochip
12/02/2004US20040241710 Methods of detecting colorectal cancer
12/02/2004US20040241706 Such as 2-amino-6-O-(2',2'-dimethyl)propyl-9-N-benzylpurine with modified guanosine triphosphate groups, which affects activity of mutant strains rather than wild-type strains; enzyme inhibitors; host cells; solid phase synthesis
12/02/2004US20040241704 Method for bisulfite treatment
12/02/2004US20040241673 Non-cytotoxic pap mutants
12/02/2004US20040241650 Computer-directed assembly of a polynucleotide encoding a target polypeptide
12/02/2004US20040241649 Rna containing coenzymes, biotin, or fluorophores, and methods for their preparation and use
12/02/2004US20040241643 Oligonucleotides for detecting infection of human blood; microarrays and disease diagnosis
12/02/2004US20040238369 Stepwise chemical synthesis of oligomers such as oligonucleotides
12/02/2004CA2526985A1 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
12/02/2004CA2526409A1 Nucleic acid processing methods, kits and devices
12/02/2004CA2525954A1 Ura5 gene and methods for stable genetic integration in yeast
12/02/2004CA2524675A1 Markers for lxr activation
12/02/2004CA2523789A1 Genes encoding carotenoid compounds
12/02/2004CA2523786A1 A .delta.-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
12/01/2004EP1482044A2 Multivariant IL-3 hematopoiesis fusion protein
12/01/2004EP1481983A1 Nucleoside analogues and oligonucleotide derivative comprising nucleotide analogue thereof
12/01/2004EP1481096A1 Surface modification, linker attachment, and polymerization methods
12/01/2004EP1481088A2 Polynomial amplification of nucleic acids
12/01/2004EP1481085A2 Oligonucleotide analogues and methods of use for modulating gene expression
12/01/2004EP1481057A1 System and method for the production of recombinant glycosylated proteins in a prokaryotic host
12/01/2004EP1481011A1 Monoclonal and polyclonal antibodies recognizing coagulase-negative staphylococcal proteins
12/01/2004EP1480995A2 Cks1 INHIBITORS
12/01/2004EP1480927A2 A method for cleavage of labile functional groups from chemical compounds
12/01/2004EP1480665A2 Peptides for recognition and targeting of glial cell tumors
12/01/2004EP1196539A4 Substrates for nucleic acid immobilization onto solid supports
12/01/2004EP0906448A4 Methods for the diagnosis and prognosis of cancer
12/01/2004CN1551919A 治疗性结合分子 Therapeutic binding molecules
12/01/2004CN1550556A Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
12/01/2004CN1550552A Clone of Chinese wildrye drought-resistant gene HVAI
12/01/2004CN1550551A Mouse nidogen gene starter and its tissue specificity enhancer
12/01/2004CN1177864C Novel human protein with expression difference in liver cancer tissue and its coding sequence
12/01/2004CN1177862C Human NIP2 associated protein and coding sequence and application thereof
12/01/2004CN1177615C Arteriovenous and venous graft treatment methods and compsns.
11/2004
11/30/2004US6825342 Plant starch composition
11/30/2004US6825340 Mixing composition with reducing agent, heating; wherein any ribonucleases in composition are substantially inactivated or inhibited
11/30/2004US6825339 Immobilization to porous solid support; oxidation using iodine in glacial acetic acid
11/30/2004US6825338 Selective functionalization of oligonucleotides with conjugate groups without the need for post-synthetic labeling; solid phase synthesis; deblocking an acid labile hydroxyl group and reacting with a phosphoramidite
11/30/2004US6825331 Aminooxy functionalized oligomers, oligomer arrays and methods of using them
11/30/2004US6825328 Lafora's disease gene
11/30/2004US6825324 Antibodies to receptor protein tyrosine kinases
11/30/2004US6825035 For drug screening; gene knockout; genetic engineering
11/30/2004US6825009 Method for identifying polymorphisms
11/30/2004US6824981 Reporter signals for use as diagnostic tools in genetic engineering
11/30/2004US6824782 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
11/30/2004CA2430586A1 Population profiling materials and methods
11/30/2004CA2428972A1 Conditional knockout method for gene trapping and gene targeting using an inducible gene silencer
11/30/2004CA2175483C Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics
11/30/2004CA2103062C Oligo-2'-deoxynucleotides and their use as pharmaceutical agents with antiviral activity
11/30/2004CA2072350C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
11/25/2004WO2004102152A2 Improved porous device
11/25/2004WO2004101809A2 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
11/25/2004WO2004101786A1 TRANSFORMING GROWTH FACTOR-β RESPONSE ELEMENT DECOYS AND METHODS BASED THEREON
11/25/2004WO2004101766A2 Grp94-based compositions and methods of use thereof
11/25/2004WO2004101764A2 Methods of modulating metastasis and skeletal related events resulting from metastases
11/25/2004WO2004101753A2 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
11/25/2004WO2004101750A2 IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES
11/25/2004WO2004101748A2 A method of increasing yield in a plant and genes useful therefor
11/25/2004WO2004101747A2 Identification and use of gpr54 and its ligands for reproductive disorders and contraception
11/25/2004WO2004101746A2 Production of carotenoids in microorganisms
11/25/2004WO2004101739A2 Methods for chemically synthesizing immunoglobulin chimeric proteins
11/25/2004WO2004100773A2 Diagnostic and therapeutic treatments related to mitochondrial disorders
11/25/2004WO2004080395A3 Methods and compositions for cancer treatment
11/25/2004WO2004072247A3 Polymerase-based protocols for generating chimeric and combinatorial chimeric oligonucleotides
11/25/2004WO2004045364A3 Methods of detecting ovarian neoplasia
11/25/2004WO2003085094A3 Solid phase methods for polynucleotide production
11/25/2004US20040237138 Method of increasing yield in a plant and genes useful therefor
11/25/2004US20040236093 Using chimeric dendritic cells comprising viral epitopes to generate vaccines to prevent and treat viral diseases
11/25/2004US20040236090 Methods and materials relating to fibulin like polypeptides and polynucleotides
11/25/2004US20040235778 Methods for regulating hematopoiesis using CpG-oligonucleotides
11/25/2004US20040235777 Enhancing immune response to cancer antigen comprising by administering a CpG (cytosine-phosphate diester-guanine) oligonucleotide; thrombopoiesis, anemia
11/25/2004US20040235775 Inhibition of hepatitis B virus (HBV) replication by RNA interference
11/25/2004US20040235773 Stability, nuclease, solubility, cell permeability, nontoxic; polymer conjugates containing nucleotides and/or oligonucleotides; antisense agents
11/25/2004US20040235768 Human platelet F11 receptor
11/25/2004US20040235715 Obtaining mammalian cells which contain a nucleic acid coding sequence for the bikunin, culturing cells in culture system under conditions sufficient to allow cells to express bikunin, the mammalian cells being capable of glycosylating the bikunin, recovering glycosylated bikunin
11/25/2004US20040235164 Antisense nucleotide sequences for use in the prevention and treatment of asthmatic disorders; gene expression ihibition
11/25/2004US20040235138 Compositions, methods and kits for determining the presence of Trichomonas vaginalis in a test sample
11/25/2004US20040235127 PUFA polyketide synthase systems and uses thereof
11/25/2004US20040235115 Comprises serine protease for use in treating and preventing heart attack, stroke, gangrene, deep venous thrombosis and peripheral arterial occlusion; fibrinolytic therapy
11/25/2004US20040235112 Enzymatic polypeptide for use in detection of modulators for prevention a nd treatment of inflammatory, cell proliferative and autoimmune diseases; enzyme inhibitors
11/25/2004US20040235111 Tumor supressor gene p33ING2
11/25/2004US20040235110 Immunoglobulin for use in identifying polypeptides which inhibit cell proliferation; immunoassay; immunodiagnostics
11/25/2004US20040235109 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/25/2004US20040235104 Nucleotide sequences coding similar expression of fibroblast growth factors genes (SEF) for use as tools in identifying modulators of cardiovascular, urogenital and cell proliferative disorders
11/25/2004US20040235103 In vitro transfromation; polypeptides; genetic engineering
11/25/2004US20040235101 Genetic circuit clocked latch
11/25/2004US20040235092 Comprises expression vectors coding heterologous protein for use as tools in diagnosis and treatment of cell proliferative, nervous system, inflammatory and autoimmune diseases
11/25/2004US20040235073 Using nuclear and lower cytosolic localization of kruppel-like transcription factors to diagnose and prognose viability of individuals with cell proliferative disorders
11/25/2004US20040235044 Chain-shortened polynucleotide and method for preparation thereof